miR372 Promotes Progression of Liver Cancer Cells by Upregulating erbB-2 through Enhancement of YB-1.

about

miR372 Promotes Progression of Liver Cancer Cells by Upregulating erbB-2 through Enhancement of YB-1.

Item

http://www.wikidata.org/entity/Q54977356

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

miR372 Promotes Progression of ...... 2 through Enhancement of YB-1.

@en

miR372 Promotes Progression of ...... 2 through Enhancement of YB-1.

@nl

type

Item

label

miR372 Promotes Progression of ...... 2 through Enhancement of YB-1.

@en

miR372 Promotes Progression of ...... 2 through Enhancement of YB-1.

@nl

prefLabel

miR372 Promotes Progression of ...... 2 through Enhancement of YB-1.

@en

miR372 Promotes Progression of ...... 2 through Enhancement of YB-1.

@nl

P1476

miR372 Promotes Progression of ...... 2 through Enhancement of YB-1.

@en

P2093

Chen Wang

http://www.w3.org/2001/XMLSchema#string

Dongdong Lu

http://www.w3.org/2001/XMLSchema#string

Hu Pu

http://www.w3.org/2001/XMLSchema#string

Jiao Li

http://www.w3.org/2001/XMLSchema#string

Jie Xu

http://www.w3.org/2001/XMLSchema#string

Qidi Zheng

http://www.w3.org/2001/XMLSchema#string

Qiuyu Meng

http://www.w3.org/2001/XMLSchema#string

Song Jia

http://www.w3.org/2001/XMLSchema#string

Tianming Li

http://www.w3.org/2001/XMLSchema#string

Wujun Xiong

http://www.w3.org/2001/XMLSchema#string

P2860

YB1/p32, a nuclear Y-box binding protein 1, is a novel regulator of myoblast differentiation that interacts with Msx1 homeoprotein

Regulation of SESAME-mediated H3T11 phosphorylation by glycolytic enzymes and metabolites.

miR-372 down-regulates the oncogene ATAD2 to influence hepatocellular carcinoma proliferation and metastasis.

PKM2 promotes cell migration and inhibits autophagy by mediating PI3K/AKT activation and contributes to the malignant development of gastric cancer.

ERRF sensitizes ERBB2-positive breast cancer cells to lapatinib treatment likely by attenuating MCL1 and ERBB2 expression

YY1-MIR372-SQSTM1 regulatory axis in autophagy

Low mir-372 expression correlates with poor prognosis and tumor metastasis in hepatocellular carcinoma

Celecoxib and acetylbritannilactone interact synergistically to suppress breast cancer cell growth via COX-2-dependent and -independent mechanisms

Noncoding RNAs that associate with YB-1 alter proliferation in prostate cancer cells.

Inhibitory effect of 2-(piperidinoethoxyphenyl)-3-(4-hydroxyphenyl)-2H-benzo(b)pyran (K-1) on human primary endometrial hyperplasial cells mediated via combined suppression of Wnt/β-catenin signaling and PI3K/Akt survival pathway.

P304

494-507

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.OMTN.2018.04.001

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29858084

http://www.w3.org/2001/XMLSchema#string

P932

5992473

http://www.w3.org/2001/XMLSchema#string